Myasthenia gravis initial symptoms

Written by Tang Bo
Neurology
Updated on September 29, 2024
00:00
00:00

Myasthenia gravis is characterized by fluctuating and fatigue-prone muscle weakness in certain specific striated muscles. Symptoms are generally milder in the morning and more severe in the evening, worsening with continued activity and alleviating after rest.

The most common initial symptom is weakness of the external eye muscles, primarily presenting as asymmetrical ptosis (drooping of the upper eyelid) or narrowing of the eye slit, along with diplopia, which refers to seeing double images. These are the most frequent initial symptoms, seen in over 50% of patients with myasthenia gravis.

Additionally, some patients may experience disturbances in eye movement, facial muscle weakness, air leakage when puffing cheeks, incomplete eyelid closure, shallower nasolabial folds, as well as difficulty swallowing, speech articulation issues, choking while drinking, and potentially severe respiratory weakness.

Other Voices

doctor image
home-news-image
Written by Zhang Hui
Neurology
55sec home-news-image

Can myasthenia gravis be cured?

Myasthenia gravis is a type of disease in the field of neurology and is categorized as an autoimmune disorder of the nervous system. Generally, this disease tends to recur easily, and it is somewhat difficult to cure completely. However, there is a subtype called ocular myasthenia gravis, where patients only show symptoms of eyelid drooping or double vision. In this type, some patients can be cured, typically around 30%. However, most patients still experience recurrent episodes, and the condition may even progress to a generalized form. Other forms of myasthenia gravis are usually more severe, involving generalized weakness and potentially difficulties in swallowing or choking on liquids. Patients with these symptoms should seek medical attention promptly and can be treated with immunosuppressants and acetylcholinesterase inhibitors to control the symptoms, though long-term medication is generally required.

doctor image
home-news-image
Written by Zhang Hui
Neurology
57sec home-news-image

The difference between amyotrophic lateral sclerosis and myasthenia gravis

These two are distinctly different diseases. Amyotrophic lateral sclerosis (ALS) refers to a motor neuron disease, which is a degenerative neurological condition primarily affecting the upper and lower motor neurons. Patients may exhibit symptoms such as muscle atrophy, muscle twitching, general weakness, as well as potential difficulties in swallowing, articulation disorders, and atrophy of the tongue muscles. The mechanism of this disease is not very clear, symptoms progressively worsen, and there are no effective treatment methods. Neurogenic changes can be observed in electromyography. Myasthenia gravis, on the other hand, is a typical neuromuscular junction disease caused by immune dysfunction. It presents with skeletal muscle fatigue and weakness, typically worsening in the evening. Treatment with immunosuppressants has been shown to be effective.

doctor image
home-news-image
Written by Xie Wen
Neurology
1min 8sec home-news-image

Myasthenia Gravis Surgical Treatment

Myasthenia gravis is an autoimmune disease, with many patients also having a thymoma. The thymus is a very important immune organ in humans, and abnormal proliferation of the thymus can produce acetylcholine receptor antibodies. These antibodies circulate to the neuromuscular junction and participate in the antigen-antibody reaction, leading to the onset of myasthenia gravis. By removing the thymus, the initiating antigens of the patient's autoimmune response can be eliminated, reducing the involvement of T cells, B cells, and cytokines in the autoimmune response. This surgery is suitable for patients with thymic hyperplasia and high acetylcholine receptor antibody titers, or those with various types of myasthenia gravis with thymoma, as well as young women with generalized myasthenia gravis, and those who are dissatisfied with cholinesterase inhibitor treatment. About 70% of patients can experience symptom relief or complete recovery after surgery.

doctor image
home-news-image
Written by Zhang Hui
Neurology
1min 16sec home-news-image

How to alleviate myasthenia gravis?

Myasthenia gravis is a disease of the department of neurology and its incidence is not low, it is also relatively common clinically. The treatment of myasthenia gravis mainly includes the following points: First, if patients with myasthenia gravis also have a thymoma, it is recommended to surgically remove the thymoma as soon as possible, which can significantly alleviate the symptoms of myasthenia gravis and reduce the amount of medication needed. Second, provide patients with some medication, mainly some drugs that suppress the immune response, including some corticosteroids. The use of corticosteroids is relatively complex, and must be gradually increased or decreased under the advice of a doctor. Do not stop taking them on your own. There are also some drugs that are cholinesterase inhibitors, which can increase the content of acetylcholine in the synaptic gap, alleviating the patient's symptoms. In addition, research has confirmed that some new immunosuppressive agents can also be used in the treatment of myasthenia gravis. In summary, the treatment of myasthenia gravis is a comprehensive subject and must be tailored according to the patient's condition.

doctor image
home-news-image
Written by Tang Bo
Neurology
1min 10sec home-news-image

Myasthenia gravis initial symptoms

Myasthenia gravis is characterized by fluctuating and fatigue-prone muscle weakness in certain specific striated muscles. Symptoms are generally milder in the morning and more severe in the evening, worsening with continued activity and alleviating after rest. The most common initial symptom is weakness of the external eye muscles, primarily presenting as asymmetrical ptosis (drooping of the upper eyelid) or narrowing of the eye slit, along with diplopia, which refers to seeing double images. These are the most frequent initial symptoms, seen in over 50% of patients with myasthenia gravis. Additionally, some patients may experience disturbances in eye movement, facial muscle weakness, air leakage when puffing cheeks, incomplete eyelid closure, shallower nasolabial folds, as well as difficulty swallowing, speech articulation issues, choking while drinking, and potentially severe respiratory weakness.